Form 4: Verizon Executive Kyle Malady Reports Stock Transactions

EVP and Group CEO of Verizon Business, Kyle Malady, reports the vesting and subsequent sale of restricted stock units, along with adjustments to his holdings of Verizon common stock.

Summary

• Kyle Malady, EVP and Group CEO of Verizon Business, filed a Form 4 detailing changes in his beneficial ownership of Verizon Communications Inc. stock.
• On March 1, 2025, Malady vested and sold 19,678 shares of common stock related to 2022 Restricted Stock Units (RSUs).
• He also vested and sold 31,914 shares of common stock related to 2023 RSUs on the same date.
• Additionally, 32,774 shares of common stock related to 2024 RSUs vested and were sold on March 1, 2025.
• The sales were executed at a price of $43.1 per share.
• Following these transactions, Malady directly owns 41,508 shares of Verizon common stock and indirectly owns 18,406 shares through his 401(k).

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock transactions, indicating a neutral sentiment. It reflects standard executive compensation practices.

Industry Context

Executive stock transactions are a routine part of corporate governance and are publicly disclosed to ensure transparency. These transactions can provide insights into an executive's perspective on the company's performance, although they are often part of pre-planned compensation and diversification strategies.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units (RSUs) that vest over time, aligning executive incentives with long-term company performance.
• Companies like AT&T and T-Mobile also utilize RSUs as part of their executive compensation plans.
• The vesting schedules and terms of RSU agreements can vary across companies, but a three-year vesting period is common.

Stakeholder Impact

• The transactions have a minimal direct impact on shareholders, as they represent a small portion of the overall outstanding shares.
• The vesting of RSUs is part of the executive's compensation package, aligning their interests with the company's performance.

Key Dates